Drug Shortage Report for CIPRO ORAL SUSPENSION
| Report ID | 180743 |
| Drug Identification Number | 02237514 |
| Brand name | CIPRO ORAL SUSPENSION |
| Common or Proper name | Ciprofloxacin Suspension |
| Company Name | BAYER INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CIPROFLOXACIN |
| Strength(s) | 500MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 100 mL |
| ATC code | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2023-03-06 |
| Actual start date | |
| Estimated end date | 2023-03-10 |
| Actual end date | 2023-03-03 |
| Shortage status | Avoided shortage |
| Updated date | 2023-03-06 |
| Company comments | Supply Constraints |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-03-06 | French | Compare |
| v7 | 2023-03-06 | English | Compare |
| v6 | 2023-02-17 | French | Compare |
| v5 | 2023-02-17 | English | Compare |
| v4 | 2023-02-06 | French | Compare |
| v3 | 2023-02-06 | English | Compare |
| v2 | 2023-01-12 | French | Compare |
| v1 | 2023-01-12 | English | Compare |
Showing 1 to 8 of 8